Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 06, 2024 20:30 ET | Source: Orion Biotechnology Canada Ltd.

Orion Biotechnology Presenting at the 3rd GPCR-Targeted Drug Discovery Summit in Boston

Ottawa, Canada, March 06, 2024 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
July 18, 2023 11:33 ET | Source: Orion Biotechnology Canada Ltd.

Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four Months

Ottawa, Canada, July 18, 2023 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
February 16, 2023 13:15 ET | Source: Orion Biotechnology Canada Ltd.

Orion Biotechnology Presenting at the 2nd GPCR-Targeted Drug Discovery Summit in Boston

Ottawa, Canada, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
February 02, 2023 10:07 ET | Source: Orion Biotechnology Canada Ltd.

Orion Biotechnology Publishes Whitepaper Highlighting the Importance and Challenges in Unlocking “Undruggable” GPCRs

Ottawa, Canada, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
December 01, 2022 11:08 ET | Source: Orion Biotechnology Canada Ltd.

Orion Biotechnology Shares In Vivo Efficacy Data on its Latest Best-in-Class Drug Candidate

Ottawa, Canada, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
November 10, 2022 09:03 ET | Source: Orion Biotechnology Canada Ltd.

Orion Biotechnology to Attend the LSX Investival Showcase and Jefferies Healthcare Conference

Ottawa, Ontario, Canada, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously...
October 11, 2022 09:03 ET | Source: Orion Biotechnology Canada Ltd.

Orion Biotechnology to present at 2022 Dr. GPCR Summit Conference

Ottawa, Canada, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
July 12, 2022 11:22 ET | Source: Orion Biotechnology Canada Ltd.

Orion Biotechnology and Peptilogics Enter Strategic Research Collaboration to Enable AI-Driven Drug Discovery Against Undrugged GPCR Target

Ottawa, Canada & Pittsburgh, USA, July 12, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd, a drug discovery company targeting previously undruggable G Protein-Coupled Receptors (GPCRs),...
July 05, 2022 10:03 ET | Source: Orion Biotechnology Canada Ltd.

ORION BIOTECHNOLOGY ADDS GPCR EXPERT TO ITS SCIENTIFIC ADVISORY BOARD

Ottawa, Canada, July 05, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd, a drug discovery and development company targeting previously-undruggable G Protein-Coupled Receptors (GPCRs), today...
May 10, 2022 13:03 ET | Source: Orion Biotechnology Canada Ltd.

ORION BIOTECHNOLOGY PRESENTING NEW DATA ON ITS LATEST BEST-IN-CLASS GPCR DRUG CANDIDATE

Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs),...

Next Page keyboard_arrow_right